Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Jan 2026.
- Notable investors include Jumpstart Pakistan.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xylexa
- ·The full record, as it builds
Funding rounds
No funding rounds for Xylexa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xylexa
Developer of a computer-aided diagnostics platform intended to assist the decision support system for radiologists and second opinions for patients. The company's platform offers diagnostics along with auto-report generation capabilities by applying AI and data analytics on human genomic and other omics data for the right time diagnostics and prediction, enabling radiologists in the early diagnosis of breast cancer through a mammogram.
- Sector
- Healthcare
- HQ
- Littleton, CO, United States
- Founded
- 2017
- Employees
- 20
- Website
- xylexa.ai/
- Ownership
- Privately Held (backing)
Xylexa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xylexa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xylexa in its N-PORT filings yet. We sweep new filings monthly.